Stebėti
Amber M. Tetlow
Amber M. Tetlow
Postdoctoral Fellow NYU Langone Health
Patvirtintas el. paštas nyulangone.org
Pavadinimas
Cituota
Cituota
Metai
Systematic review and meta-analyses of useful field of view cognitive training
JD Edwards, BA Fausto, AM Tetlow, RT Corona, EG Valdés
Neuroscience & Biobehavioral Reviews 84, 72-91, 2018
1302018
Tau-targeting therapies for Alzheimer disease: current status and future directions
EE Congdon, C Ji, AM Tetlow, Y Jiang, EM Sigurdsson
Nature Reviews Neurology 19 (12), 715-736, 2023
1132023
Systematic literature review and meta-analysis of commercially available computerized cognitive training among older adults
AM Tetlow, JD Edwards
Journal of Cognitive Enhancement 1, 559-575, 2017
782017
Auditory processing of older adults with probable mild cognitive impairment
JD Edwards, JJ Lister, MN Elias, AM Tetlow, AL Sardina, NA Sadeq, ...
Journal of Speech, Language, and Hearing Research 60 (5), 1427-1435, 2017
322017
Sphingolipid and phospholipid levels are altered in human brain in chorea‐acanthocytosis
G Miltenberger‐Miltenyi, A Jones, AM Tetlow, VA Conceição, JF Crary, ...
Movement Disorders 38 (8), 1535-1541, 2023
112023
Neural atrophy produced by AAV tau injections into hippocampus and anterior cortex of middle-aged mice
AM Tetlow, BM Jackman, MM Alhadidy, P Muskus, DG Morgan, ...
Neurobiology of aging 124, 39-50, 2023
82023
An Autopsy Series of Seven Cases of VPS13A Disease (Chorea‐Acanthocytosis)
RM Ditzel Jr, RH Walker, MJ Nirenberg, AM Tetlow, K Farrell, ...
Movement Disorders 38 (12), 2163-2172, 2023
62023
Is memory decline associated with inflammatory response?
AM Tetlow, R Andel, FJ Infurna
Journal of Aging and Health 31 (5), 783-792, 2019
42019
Single-domain antibody-based protein degrader for synucleinopathies
Y Jiang, Y Lin, AM Tetlow, R Pan, C Ji, XP Kong, EE Congdon, ...
Molecular Neurodegeneration 19 (1), 44, 2024
22024
Evaluation of commercially-available computerized cognitive training programs among older adults
A Tetlow, J Edwards
Innovation in Aging 2 (Suppl 1), 671, 2018
22018
USEFUL FIELD OF VIEW COGNITIVE TRAINING IMPROVES OLDER ADULTS’EVERYDAY FUNCTION
B Fausto, A Tetlow, R Corona, E Valdés, J Edwards
Innovation in Aging 2 (suppl_1), 680-680, 2018
12018
Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy
C Ji, X Yang, M Eleish, Y Jiang, AM Tetlow, SC Song, A Martín‐Ávila, ...
Alzheimer's & Dementia 20 (11), 7954-7970, 2024
2024
An autopsy series of seven genetically confirmed cases of chorea acanthocytosis (VPS13A disease)
R Ditzel, R Walker, M Nirenberg, A Tetlow, K Lind-Watson, K Farrell, ...
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 82 (6), 508-508, 2023
2023
Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy
AM Tetlow, BM Jackman, MM Alhadidy, V Perumal, DG Morgan, ...
Journal of Alzheimer’s Disease 93 (1), 365-378, 2023
2023
GAPS & CONTROVERSIES
GD Pal, DM Corcos, LV Metman, Z Israel, H Bergman, D Arkadir, ...
2023
Evaluation of Aging and Genetic Mutation Variants on Tauopathy
AM Tetlow
University of South Florida, 2020
2020
P4‐158: CHANGES ACROSS THE LIFESPAN IN TG4510 MICE
AM Tetlow, A Joly-Amado, MN Gordon, D Morgan
Alzheimer's & Dementia 15, P1335-P1335, 2019
2019
P4‐039: A NOVEL HISTONE DEACETYLASE 6 (HDAC6) INHIBITOR TO MITIGATE TAU PATHOLOGY IN ALZHEIMER'S DISEASE
MM Alhadidy, AS Soliman, AM Tetlow, B Kara, A Kozikowski, MN Gordon, ...
Alzheimer's & Dementia 15, P1289-P1289, 2019
2019
P3‐176: AGE AS A PREDICTOR OF DIFFERENT PHYSIOLOGICAL FORMS OF TAU
AM Tetlow, A Joly-Amado, MN Gordon, D Morgan
Alzheimer's & Dementia 14 (7S_Part_21), P1135-P1135, 2018
2018
CAN A CHANGE IN COGNITION PREDICT C-REACTIVE PROTEIN LEVELS?
A Tetlow, R Andel, FJ Infurna
GERONTOLOGIST 56, 185-185, 2016
2016
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20